08.05.26 -- Global Ties, Good Fortune Bind Biotech And CDMO

Critical formulation deficiencies were solved through batch manufacturing and process adjustments. This enabled a 30% reduction in time-to-manufacture and prevented delays to the start date.

For complex projects involving oral solid dosage (OSD) and sterile drug products, selecting the ideal CDMO can play a pivotal role in determining the success of a drug candidate.

Discover three tools that facilitate a successful journey from candidate compound to clinical triumph: solid form screening, PBPK modeling, and AI-enabled route scouting.

‘Brick dust’ compounds require additional steps if spray drying is to yield a commercially attractive process. Explore enabling technologies designed to improve drug solubility in organic solvents.

The significant interest in semi-solid systems for the potential of extended release profiles has prompted researchers to develop alternative encapsulating systems. 

Learn practical strategies to strengthen development, reduce risk, and make smarter partnership decisions that can help advance your next program with confidence.

Integrated drug development streamlines manufacturing, analytics, and supply to cut risk and speed timelines. Inhalation advances and flexible partnerships help therapies reach commercialization faster.

Integrating lab notebooks with inventory and asset tracking boosts accuracy and traceability. Real-time visibility cuts errors, speeds decisions, and supports compliant, scalable pharma development.

Teams face rising pressure around compliance, complexity, and speed. These five essential qualities help identify packaging partners who can support production, reduce risk, and align with your needs.